MedPath

Management of spinal hemangioblastoma

Conditions
D33.4
Spinal cord
Registration Number
DRKS00033224
Lead Sponsor
niversitätsklinikum Freiburg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
200
Inclusion Criteria

Adult patients treated for spinal hemangioblastoma from January 1980 to December 2023.

Exclusion Criteria

Patient age <18 years at the time of treatment of spinal hemangioblastoma.
Data not analyzable.

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath